false
0000065770
0000065770
2026-08-06
2026-08-06
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
DATE
OF REPORT (DATE OF EARLIEST EVENT REPORTED) August 6, 2026
MicroVision,
Inc.
(Exact
name of registrant as specified in its charter)
| Delaware |
|
001-34170 |
|
91-1600822 |
(State
or other jurisdiction
of
incorporation) |
|
(Commission
File
Number) |
|
(I.R.S.
Employer
Identification
No.) |
18390
NE 68th Street
Redmond,
Washington 98052
(Address
of principal executive offices) (Zip code)
(425)
936-6847
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former
name or former address if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| |
☐ |
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
|
| |
☐ |
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
|
| |
☐ |
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
|
| |
☐ |
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
symbol(s) |
|
Name
of each exchange on which registered |
| Common
stock, par value $0.001 per share |
|
MVIS |
|
The
NASDAQ Stock Market |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
2.02. Results of Operations and Financial Condition.
The
information in this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the
Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current
Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933,
as amended.
On
August 6, 2026, MicroVision, Inc. issued a press release announcing its second quarter 2026 results. A copy of the press release is attached
as Exhibit 99.1 and is incorporated herein by reference.
Item
9.01. Financial Statements and Exhibits.
(c)
Exhibits.
Pursuant
to the rules and regulations of the SEC, the attached exhibit is deemed to have been furnished to, but not filed with, the SEC.
| |
Exhibit
No. |
|
Description |
| |
99.1 |
|
Press Release of MicroVision, Inc. dated August 6, 2026 |
| |
104 |
|
Cover Page Interactive File (the cover page tags are
embedded within the Inline XBRL document) |
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| |
MICROVISION, INC. |
| |
|
|
| |
By: |
/s/ Drew
G. Markham |
| |
|
Drew G. Markham |
| |
|
Senior Vice President, General Counsel and Secretary |
Dated:
August 6, 2026
Exhibit
99.1
MicroVision
Reports Second Quarter 2026 Results and Highlights Commercial Momentum Across Multiple Markets
Advancing
Lidar 2.0 strategy with expanding customer engagements, new product launches, strengthened leadership team, improved cash burn guidance,
and growing commercial pipeline
REDMOND,
Wash. – August 6, 2026 – MicroVision, Inc. (NASDAQ: MVIS), a leader in advanced perception solutions for industrial,
security and defense, and automotive applications, today announced its second quarter 2026 results and provided a business update highlighting
continued execution of its Lidar 2.0 strategy.
Key
Operational Highlights
| ● | Advanced
the Company’s Lidar 2.0 strategy, expanding MicroVision’s position as a perception
solutions provider serving industrial, security & defense, automotive, robotics, and
autonomous aerial markets. |
| ● | Launched
the MOVIA™ Air product family, with several pre-launch partners, introducing both
MOVIA™ Air and MOVIA™ Air Plus, purpose-built airborne perception solutions designed
for drones, autonomous aircraft, and defense applications. |
| ● | Signed
a long-term development agreement with a leading construction and mining equipment OEM
to integrate IRIS lidar into next-generation autonomous hauling vehicles, and bridge to integration
of the Company’s next-gen HALO lidar. |
| | | |
| | ● | Fulfilled
increasing demand for active evaluations with customers spanning target markets, including
with a leading AI company and hyperscaler for robotics and autonomous systems, a leading
e-commerce company for aerial logistics and delivery, a defense contractor for mission-ready
ground autonomy, and more.
|
| ● | Shipped
IRIS and MOVIA sensors supporting customer programs across industrial automation, autonomous
systems, aerospace, defense, and artificial intelligence applications. |
| ● | Launched
MicroVision Semiconductor, establishing an in-house semiconductor organization that expands
the Company’s custom ASIC, mixed-signal IC and advanced imaging capabilities while
supporting both internal product development and external customer programs. |
| ● | Strengthened
the executive leadership team with the appointments of James Byun as Chief Commercial
Officer and Cara Klaer as Head of Marketing & Communications. |
| ● | Improved
full-year cash burn guidance to approximately $60 million, reflecting expected normalization
in the second half of the year following non-recurring cash usage in the first half, with
improvement due to continued operational discipline and acquisition synergies. |
| ● | Completed
a 1-for-15 reverse stock split, strengthening the Company’s capital markets position
and supporting continued Nasdaq listing compliance. |
“Our
second quarter demonstrates that MicroVision has evolved into a commercially focused perception company with the products, technology,
leadership and operational discipline needed to compete across multiple high-growth markets,” said Glen DeVos, Chief Executive
Officer of MicroVision. “Our Lidar 2.0 strategy is translating into meaningful commercial momentum and a path to near-term and
future revenue.”
“Our
strategy is simple: deliver the right perception solutions at the right cost across multiple industries. We’re leveraging a common
technology platform to address opportunities spanning industrial automation, security and defense, autonomous aerial systems, robotics
and automotive. Every new customer, product and market reinforces the scalability of our business model and the trajectory of our revenue
growth.”
Key
Financial Highlights for Q2 2026
| ● | Revenue
for the second quarter of 2026 was $1.5 million, compared to $0.2 million for the second
quarter of 2025, primarily as a result of a greater volume of sensors shipped, as well as
development revenue, during the second quarter of 2026. |
| ● | Total
operating expenses for the second quarter of 2026 were $24.9 million, compared to $14.1 million
for the second quarter of 2025, with the increase primarily relating to costs stemming from
the acquisitions, along with integration and consolidation activities, during the second
quarter of 2026. |
| ● | Net
loss for the second quarter of 2026 was $36.9 million, or $1.66 per share, compared to a
net loss of $14.2 million, or $0.84 per share, for the second quarter of 2025. |
| ● | Per
share amounts have been adjusted to reflect the 1-for-15 reverse stock split that became
effective on August 1, 2026. |
| ● | Adjusted
EBITDA for the second quarter of 2026 was a $18.8 million loss, compared to a $11.2 million
loss for the second quarter of 2025. |
| ● | Cash
used in operations in the second quarter of 2026 was $19.1 million, which includes non-recurring
payments related to acquisition and consolidation activities, compared to cash used in operations
in the second quarter of 2025 of $12.7 million. |
| ● | The
Company ended the second quarter of 2026 with $27.2 million in cash and cash equivalents,
including investment securities, compared to $74.8 million at December 31, 2025. |
As
of June 30, 2026, the Company has access to $68.4 million of capital, subject to certain conditions, including $41.2 million under its
existing ATM, or at-the-market, facility and expects future financing activities to support continued execution of its strategic plan.
Conference
Call
MicroVision
will host a conference call today at 4:30 p.m. Eastern Time to discuss second quarter 2026 financial results and provide a business
update.
The
live webcast can be accessed on the Investor Relations section of the Company’s website at www.microvision.com. A
replay of the webcast will be available following the conclusion of the call.
About
MicroVision
MicroVision
is defining the next generation of lidar-based perception solutions for automotive, industrial, and security & defense markets. As
the industry moves beyond proof of concept toward value, deployment, and commercialization, MicroVision delivers integrated hardware
and software solutions designed for real-world performance, automotive-grade reliability, and economic scalability. With engineering
centers in the U.S. and Germany, MicroVision leads the industry in depth and breadth of its portfolio, with both short- and long-range
lidar solutions, featuring solid-state sensors with varying wavelengths, advanced sensor architectures, design-to-cost engineering, and
open software solutions.
For
more information, visit the Company’s website at www.microvision.com, on Facebook at www.facebook.com/microvisioninc,
and LinkedIn at https://www.linkedin.com/company/microvision/.
MicroVision,
MAVIN, MOSAIK, MOVIA, IRIS, and SENTINEL are trademarks of MicroVision, Inc. in the United States and other countries. All other trademarks
are the properties of their respective owners.
Non-GAAP
Information
To
supplement MicroVision’s condensed financial statements presented in accordance with GAAP, the Company presents investors with
the non-GAAP financial measures “adjusted EBITDA” and “adjusted Gross Profit.” Adjusted EBITDA consists of GAAP
net income (loss) excluding the impact of the following: interest income and interest expense; income tax expense; depreciation and amortization;
non-cash gains and losses; share-based compensation; restructuring costs; acquisition-related costs; and impairment charges. Adjusted
Gross Profit is calculated as GAAP gross profit before share-based compensation expense, inventory write downs, and the amortization
of acquired intangibles included in cost of revenue.
MicroVision
believes that the presentation of adjusted EBITDA and adjusted Gross Profit provides important supplemental information to management
and investors regarding financial and business trends, provides consistency and comparability with MicroVision’s past financial
reports, and facilitates comparisons with other companies in the Company’s industry, many of which use similar non-GAAP financial
measures to supplement their GAAP results. Internally, management uses these non-GAAP measures when evaluating operating performance
because the exclusion of the items described above provides an additional useful measure of the Company’s operating results and
facilitates comparisons of the Company’s core operating performance against prior periods and its business objectives. Externally,
the Company believes that adjusted EBITDA and adjusted Gross Profit are useful to investors in their assessment of MicroVision’s
operating performance and the valuation of the Company.
Adjusted
EBITDA and adjusted Gross Profit are not calculated in accordance with GAAP, and should be considered supplemental to, and not as a substitute
for, or superior to, financial measures calculated in accordance with GAAP. Non-GAAP financial measures have limitations in that they
do not reflect all of the costs associated with the operations of MicroVision’s business as determined in accordance with GAAP.
The Company expects to continue to incur expenses similar to the non-GAAP adjustments described above, and exclusion of these items from
its non-GAAP financial measures should not be construed as an inference that these costs are unusual or infrequent.
The
Company compensates for limitations of the adjusted EBITDA measure by prominently disclosing GAAP net income (loss), which the Company
believes is the most directly comparable GAAP measure, and providing investors with a reconciliation from GAAP net income (loss) to adjusted
EBITDA.
Similarly
for adjusted Gross Profit, the Company compensates for limitations of the measure by prominently disclosing GAAP gross profit which is
the difference between Revenue and Cost of revenue, which the Company believes is the most directly comparable GAAP measure, and providing
investors with a reconciliation by backing out share-based compensation expense and the amortization of acquired intangibles included
in cost of revenue.
Forward-Looking
Statements
Certain
statements contained in this release, including market position, expectations, and likelihood of success; opportunities for customer
engagement and revenue; expense reduction; benefits of acquisitions and integration synergies; market position; product portfolio; product
and manufacturing capabilities; transaction benefits; access to capital and capital-raising opportunities; and expected revenue, expenses
and cash usage are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ
materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those projected
in such forward-looking statements include the risk its ability to operate with limited cash or to raise additional capital when needed;
market acceptance of its technologies and products or for products incorporating its technologies; the failure of its commercial partners
to perform as expected under its agreements; its financial and technical resources relative to those of its competitors; its ability
to keep up with rapid technological change; government regulation of its technologies; its ability to enforce its intellectual property
rights and protect its proprietary technologies; the ability to obtain customers and develop partnership opportunities; the timing of
commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence
on third parties to develop, manufacture, sell and market its products; potential product liability claims; its ability to maintain its
listing on The Nasdaq Stock Market, and other risk factors identified from time to time in the Company’s SEC reports, including
the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed with the SEC. These factors are
not intended to represent a complete list of the general or specific factors that may affect the Company. It should be recognized that
other factors, including general economic factors and business strategies, may be significant, now or in the future, and the factors
set forth in this release may affect the Company to a greater extent than indicated. Except as expressly required by federal securities
laws, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information,
future events, changes in circumstances or any other reason.
Investor
Relations Contact
Jeff
Christensen
Darrow
Associates Investor Relations
MVIS@darrowir.com
Media
Contact
Heidi
Davidson - For MicroVision
heidi@galvanizeworldwide.com
(914)
441-6862
MicroVision,
Inc.
Consolidated
Balance Sheets
(In
thousands)
| | |
June 30, | | |
December 31, | |
| | |
2026 | | |
2025 | |
| | |
| | |
| |
| Assets | |
| | | |
| | |
| Current assets | |
| | | |
| | |
| Cash and cash equivalents | |
$ | 27,208 | | |
$ | 32,363 | |
| Investment securities, available-for-sale | |
| - | | |
| 42,471 | |
| Restricted cash, current | |
| 482 | | |
| 497 | |
| Accounts receivable, net of allowances | |
| 915 | | |
| 47 | |
| Inventory | |
| 3,660 | | |
| 745 | |
| Other current assets | |
| 2,021 | | |
| 4,989 | |
| Total current assets | |
| 34,286 | | |
| 81,112 | |
| | |
| | | |
| | |
| Property and equipment, net | |
| 15,787 | | |
| 4,280 | |
| Operating lease right-of-use assets | |
| 17,655 | | |
| 14,075 | |
| Restricted cash, net of current portion | |
| 1,184 | | |
| 1,204 | |
| Intangible assets, net | |
| 13,684 | | |
| 32 | |
| Goodwill | |
| 3,677 | | |
| - | |
| Other assets | |
| 2,334 | | |
| 2,416 | |
| Total assets | |
$ | 88,607 | | |
$ | 103,119 | |
| | |
| | | |
| | |
| Liabilities and shareholders’ equity | |
| | | |
| | |
| Current liabilities | |
| | | |
| | |
| Accounts payable | |
$ | 5,876 | | |
$ | 1,628 | |
| Accrued liabilities | |
| 7,511 | | |
| 5,426 | |
| Deferred revenue | |
| 253 | | |
| - | |
| Derivative liability | |
| 7,050 | | |
| - | |
| Notes payable | |
| 24,559 | | |
| 19,212 | |
| Operating lease liabilities, current | |
| 5,119 | | |
| 3,481 | |
| Finance lease liabilities, current | |
| 13 | | |
| 14 | |
| Other current liabilities | |
| 43 | | |
| 388 | |
| Total current liabilities | |
| 50,424 | | |
| 30,149 | |
| | |
| | | |
| | |
| Warrant liability | |
| 380 | | |
| 1,875 | |
| Operating lease liabilities, net of current portion | |
| 15,743 | | |
| 14,034 | |
| Finance lease liabilities, net of current portion | |
| 17 | | |
| 27 | |
| Other long-term liabilities | |
| 1,424 | | |
| 1,486 | |
| Total liabilities | |
| 67,988 | | |
| 47,571 | |
| | |
| | | |
| | |
| Commitments and contingencies | |
| | | |
| | |
| Shareholders’ equity | |
| | | |
| | |
| Common stock at par value | |
| 23 | | |
| 20 | |
| Additional paid-in capital | |
| 1,039,358 | | |
| 1,012,121 | |
| Accumulated other comprehensive income | |
| 737 | | |
| 669 | |
| Accumulated deficit | |
| (1,019,499 | ) | |
| (957,262 | ) |
| Total shareholders’ equity | |
| 20,619 | | |
| 55,548 | |
| Total liabilities and shareholders’ equity | |
$ | 88,607 | | |
$ | 103,119 | |
MicroVision,
Inc.
Consolidated
Statement of Operations
(In
thousands, except per share data)
| | |
Three months ended June 30, | | |
Six months ended June 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
| | |
| | |
| | |
| |
| Revenue | |
$ | 1,473 | | |
$ | 155 | | |
$ | 2,408 | | |
$ | 744 | |
| | |
| | | |
| | | |
| | | |
| | |
| Cost of revenue | |
| 831 | | |
| 716 | | |
| 1,403 | | |
| 1,266 | |
| Gross profit (loss) | |
| 642 | | |
| (561 | ) | |
| 1,005 | | |
| (522 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Research and development expense | |
| 15,702 | | |
| 7,658 | | |
| 30,147 | | |
| 15,061 | |
| Sales, marketing, general and administrative expense | |
| 9,211 | | |
| 6,437 | | |
| 18,722 | | |
| 13,113 | |
| Impairment loss on operating lease right-of-use assets | |
| - | | |
| - | | |
| 9 | | |
| - | |
| Gain on disposal of fixed assets | |
| (60 | ) | |
| - | | |
| (168 | ) | |
| - | |
| Total operating expenses | |
| 24,853 | | |
| 14,095 | | |
| 48,710 | | |
| 28,174 | |
| | |
| | | |
| | | |
| | | |
| | |
| Loss from operations | |
| (24,211 | ) | |
| (14,656 | ) | |
| (47,705 | ) | |
| (28,696 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Interest expense | |
| (5,480 | ) | |
| (2,170 | ) | |
| (8,233 | ) | |
| (15,073 | ) |
| Unrealized gain (loss) on derivative liability | |
| (8,035 | ) | |
| 1,952 | | |
| (4,655 | ) | |
| 2,794 | |
| Unrealized gain on warrant liability | |
| 891 | | |
| 803 | | |
| 1,495 | | |
| 2,564 | |
| Realized loss on debt extinguishment | |
| - | | |
| - | | |
| (3,083 | ) | |
| (4,654 | ) |
| Bargain purchase gain | |
| - | | |
| - | | |
| 147 | | |
| - | |
| Other income (expense) | |
| 73 | | |
| (65 | ) | |
| 160 | | |
| 223 | |
| | |
| | | |
| | | |
| | | |
| | |
| Net loss before taxes | |
$ | (36,762 | ) | |
$ | (14,136 | ) | |
$ | (61,874 | ) | |
$ | (42,842 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Income tax expense | |
| (181 | ) | |
| (93 | ) | |
| (363 | ) | |
| (166 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Net loss | |
$ | (36,943 | ) | |
$ | (14,229 | ) | |
$ | (62,237 | ) | |
$ | (43,008 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Net loss per share - basic and diluted | |
$ | (1.66 | ) | |
$ | (0.84 | ) | |
$ | (2.90 | ) | |
$ | (2.63 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Weighted-average shares outstanding - basic and diluted | |
| 22,296 | | |
| 16,977 | | |
| 21,441 | | |
| 16,356 | |
MicroVision,
Inc.
Consolidated
Statements of Cash Flows
(In
thousands)
| | |
Six months ended June 30, | |
| | |
2026 | | |
2025 | |
| | |
| | |
| |
| Cash flows from operating activities | |
| | | |
| | |
| Net loss | |
$ | (62,237 | ) | |
$ | (43,008 | ) |
| Adjustments to reconcile net loss to net cash used in operations: | |
| | | |
| | |
| Depreciation and amortization | |
| 5,344 | | |
| 2,952 | |
| Unrealized gain (loss) on derivative liability | |
| 4,655 | | |
| (2,794 | ) |
| Unrealized gain on warrant liability | |
| (1,495 | ) | |
| (2,564 | ) |
| Loss on debt extinguishment | |
| 3,083 | | |
| 4,654 | |
| Bargain purchase gain | |
| (147 | ) | |
| - | |
| Gain on disposal of fixed assets | |
| (168 | ) | |
| - | |
| Impairment of operating lease right-of-use assets | |
| 9 | | |
| - | |
| Inventory write-downs | |
| 52 | | |
| - | |
| Non-cash interest expense | |
| - | | |
| 7,325 | |
| Amortization of debt discount and issuance costs on notes payable | |
| 8,219 | | |
| 7,723 | |
| Share-based compensation expense | |
| 2,287 | | |
| 3,851 | |
| Net accretion of premium on short-term investments | |
| (81 | ) | |
| (195 | ) |
| Change in: | |
| | | |
| | |
| Accounts receivable | |
| (868 | ) | |
| 822 | |
| Inventory | |
| 833 | | |
| (3,796 | ) |
| Other current and non-current assets | |
| 1,115 | | |
| (210 | ) |
| Accounts payable | |
| 4,248 | | |
| 432 | |
| Accrued liabilities | |
| 2,085 | | |
| (275 | ) |
| Contract liabilities and other current liabilities | |
| (92 | ) | |
| (450 | ) |
| Operating lease liabilities | |
| (2,409 | ) | |
| (1,097 | ) |
| Other long-term liabilities | |
| (21 | ) | |
| (197 | ) |
| Net cash used in operating activities | |
| (35,588 | ) | |
| (26,827 | ) |
| | |
| | | |
| | |
| Cash flows from investing activities | |
| | | |
| | |
| Sales of investment securities | |
| 42,528 | | |
| 22,402 | |
| Purchases of investment securities | |
| - | | |
| (19,326 | ) |
| Cash paid for business combination | |
| (33,178 | ) | |
| - | |
| Purchases of property and equipment | |
| (448 | ) | |
| (307 | ) |
| Net cash provided by investing activities | |
| 8,902 | | |
| 2,769 | |
| | |
| | | |
| | |
| Cash flows from financing activities | |
| | | |
| | |
| Principal payments under finance leases | |
| (8 | ) | |
| (6 | ) |
| Principal proceeds from notes payable, net of debt discount and issuance costs | |
| 20,624 | | |
| - | |
| Net proceeds from issuance of common stock and warrants | |
| 769 | | |
| 43,289 | |
| Net cash provided by financing activities | |
| 21,385 | | |
| 43,283 | |
| | |
| | | |
| | |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | |
| 111 | | |
| 319 | |
| | |
| | | |
| | |
| Change in cash, cash equivalents, and restricted cash | |
| (5,190 | ) | |
| 19,544 | |
| Cash, cash equivalents, and restricted cash at beginning of period | |
| 34,064 | | |
| 56,247 | |
| Cash, cash equivalents, and restricted cash at end of period | |
$ | 28,874 | | |
$ | 75,791 | |
The
following table provides a reconciliation of the cash, cash equivalents, and restricted cash balances as of June 30, 2026 and
2025:
| | |
June 30, | | |
June 30, | |
| | |
2026 | | |
2025 | |
| Cash and cash equivalents | |
$ | 27,208 | | |
$ | 74,094 | |
| Restricted cash, current | |
| 482 | | |
| 76 | |
| Restricted cash, net of current portion | |
| 1,184 | | |
| 1,621 | |
| Cash, cash equivalents, and restricted cash | |
$ | 28,874 | | |
$ | 75,791 | |
MicroVision,
Inc.
Reconciliation
of GAAP to Non-GAAP Measures
(In
thousands)
| | |
Three months ended June 30, | | |
Six months ended June 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
| | |
| | |
| | |
| |
| Reconciliation of Non-GAAP Gross Profit: | |
| | | |
| | | |
| | | |
| | |
| Gross profit (loss) | |
$ | 642 | | |
$ | (561 | ) | |
$ | 1,005 | | |
$ | (522 | ) |
| Inventory related write-downs | |
| 25 | | |
| - | | |
| 52 | | |
| - | |
| Amortization of acquired intangibles | |
| - | | |
| 217 | | |
| - | | |
| 434 | |
| Adjusted Gross Profit | |
$ | 667 | | |
$ | (344 | ) | |
$ | 1,057 | | |
$ | (88 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Reconciliation of Non-GAAP Loss: | |
| | | |
| | | |
| | | |
| | |
| GAAP Net loss | |
$ | (36,943 | ) | |
$ | (14,229 | ) | |
$ | (62,237 | ) | |
$ | (43,008 | ) |
| Interest expense, net | |
| 5,407 | | |
| 2,235 | | |
| 8,073 | | |
| 14,850 | |
| Provision for income taxes | |
| 181 | | |
| 93 | | |
| 363 | | |
| 166 | |
| Depreciation and amortization | |
| 2,976 | | |
| 1,544 | | |
| 5,344 | | |
| 2,952 | |
| Unrealized (gain) loss on derivative liability | |
| 8,035 | | |
| (1,952 | ) | |
| 4,655 | | |
| (2,794 | ) |
| Unrealized gain on warrant liability | |
| (891 | ) | |
| (803 | ) | |
| (1,495 | ) | |
| (2,564 | ) |
| Loss on debt extinguishment | |
| - | | |
| - | | |
| 3,083 | | |
| 4,654 | |
| Gain on disposal of fixed assets | |
| (60 | ) | |
| - | | |
| (168 | ) | |
| - | |
| Impairment of operating lease right-of-use assets | |
| - | | |
| - | | |
| 9 | | |
| - | |
| Share-based compensation expense | |
| 1,304 | | |
| 1,930 | | |
| 2,287 | | |
| 3,851 | |
| Inventory related write-downs | |
| 25 | | |
| - | | |
| 52 | | |
| - | |
| Acquisition-related costs | |
| 1,143 | | |
| - | | |
| 2,870 | | |
| - | |
| Restructuring charges | |
| - | | |
| - | | |
| 1,139 | | |
| - | |
| Adjusted EBITDA | |
$ | (18,823 | ) | |
$ | (11,182 | ) | |
$ | (36,025 | ) | |
$ | (21,893 | ) |
